… drug conjugate for patients with metastatic castration-resistant prostate cancer … phase 2 monotherapy trial with the activation … inhibitor, which can include abiraterone acetate (Zytiga), enzalutamide … significantly higher on-treatment frequency of circulating …

… has led to pharmaceutical companies apparently being … own equivalent (Scottish Medicines Consortium or SMC). … the first breast cancer treatment NICE has been unable … drug called abiraterone. It has long been approved for men with incurable prostate cancer …

… Clinical Trials The clinical efficacy of microcatheter-assisted drug-loaded microspheres in prostate cancer … With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. J …

… treating advanced prostate cancer. September is Prostate Cancer Awareness Month … Early Detection Doctors stress that while … Treatments For those diagnosed, treatment options have expanded in recent years. The FDA … of niraparib and abiraterone), is designed for …

… prostate cancer, his own research showed that a drug called abiraterone … would be the best treatment for … with the NHS’s medicines watchdog NICE (the … or Metastatic Prostate Cancer: Evaluation of Drug Efficiency) trial. Led by …

… discussing the various treatment options with newly … This [trial enrolled] patients with metastatic hormone sensitive prostate cancer. … European Society for Medical Oncology Congress (ESMO … enzalutamide [Xtandi], or even abiraterone [Zytiga] because that…

… in the treatment of prostate cancer (Figure 1). The first FDA approved immunotherapy … trials are in early stages to evaluate this drug’s effectiveness in prostate cancer … and abiraterone (mCSPC) or in combination with docetaxel (mCRPC). Another trial …

… to become a leading biotech company, NovalGen is … novel treatments for cancer. The Centre for Drug Development … cancer, abiraterone for prostate cancer, and rucaparib for ovarian cancer. Two other drugs … and manufacturing of biologic medicines. Mabion is a …

… Cancer Medicine Centre (ECMC) network. The Phase 2a trial … leading pharma and biotech companies. This … treatments for cancer. The Cancer Research UK Centre for Drug … cancer, abiraterone for prostate cancer and rucaparib for ovarian cancer. Two other drugs …

… appropriate standard treatment. In this trial, patients … and Drug Administration (FDA) and European Medicines Agency … Phase III Prostate Cancer Trials Involving 177Lu- … metastatic castration resistant prostate cancer after chemotherapy, Abiraterone and/or …